Desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients;Accoutumance au trimethoprime-sulfamethoxazole chez les malades infectes par le VIH

Annales de Medecine Interne

Volumn 147, Issue 5, 1996, Pages 327-330

  Piketty, Christophe ^a   Gilquin, Jacques ^a   Kazatchkine, Michel ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

desensitization; HIV; sulfamethoxazole; trimethoprim

Indexed keywords

COTRIMOXAZOLE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DESENSITIZATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORAL DRUG ADMINISTRATION; PNEUMOCYSTOSIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-INFECTIVE AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGED; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0029823723     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. HARDY WD, FKINBKRG J, KINKELSTFIN DM et al. : A controlled trial of trimethoprim-sulfamethoxazole or aerolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327 : 1842-8.
2. SCHNEIDER M, HOEPELMAN A. KAREL J et al. : A controlled trial of aerolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992 ; 327 : 1836-41.
3. CARR A. TINDALL B, BREW B et al. : Low-dose trimethoprim-sultamethoxazole prophylaxis for toxoplasmic encephalitis in patient with AIDS. Ann Intern Med 1992 ; 117 : 106-11.
4. GORDIN FM. SIMON GL, WOFSY CB, MILLS J : Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984 ; 100: 495-9.
5. RUSKIN J, LARIVIÈRE M. : Low-dose cotrimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus diseases. Lancet 1991 ; 337: 468-71.
6. COOPMANN SA, JOHNSON RA, PLATT R, STKRN RS : Cutaneous diseases and drugs reactions in HIV infection. N Engl J Med 1993 ; 328 : 1670-4.
7. WHARTON JM, COLEMAN DL, WOFSY CB et al. : Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986 ; 105 : 37-44.
8. SAIAG P, CAUMES E, CHOSIDOW O et al. : Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992 ; 26 : 567-74.
9. SMITH RM. IWAMOTO GK, RICHERSON HB, FLAHERTY JP : Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome. Ann Intern Med 1987 ; 106 : 335.
10. KLEMOLA E : Hypersensitivity reaction to ampicillin in cytomegalovirus mononucleosis. Scan J Infect Dis 1970 ; 2 : 29-31.
11. BUHL R, JAFFE HA, HOLROYD KJ et al. : Systemic glutathion deficiency in symptom free HIV-seropositive individuals. Lancet 1989 ; 334 : 1294-8.
12. CARR A. GROSS AS, HOSKINS JM, PENNY R, COOPER DA : Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. AIDS 1994 : 8 : 333-7.
13. CLHERICI M, SHEARER GM : A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993 ; 14 : 107-11.
14. CARR A, PENNY R, COOPER DA : Efficacy and safety of rechallenge with low dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS 1993 ; 7 : 65-71.
15. CONANT M, DYBUL M : Trimethoprim-sulphamethoxazole hypersensitivity and desensitization in HIV disease. VIIIth international conference on AIDS 1992, Amsterdam. Abstract PO-B-3291.
16. RICH JD, GREINEDER D, SULLIVAN TJ, KAZANDJIAN PH : Successfull oral desensitization to TMP/SMX in persons with HIV infection and prior hypersensitive reactions. IXth international conference on AIDS 1993, Berlin. Abstract PO-B10-1482.
17. TORGOVNICK J, ARSURA E : Desensitization to sulfonamides in patients with HIV infection. Am J Med 1990 ; 88 : 548-9.
18. WHITE MV, HADDAD ZH, BRUNNER E, SAINZ C : Desensitization to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Ann Allergy 1989 ; 62 : 177-9.
19. JUNG AC. PAAUW DS : Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch Intern Med 1994 ; 154 : 2402-6.
20. MORENO JN, POBLETE RB, MAGGIO C, GAGNON S, FlSCHL MA : Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome. Ann Allergy Asthma Immunol 1995 ; 74 : 140-6.
21. ABSAR N, DANESHVAR H, BEALL G : Desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol 1994 ; 93 : 1001-5.
22. BACHMEYER C, SALMON D, GUERIN C et al. : Trimethoprim-sulfamethoxazole desensitization in HIV-infected patients : an open study. AIDS 1995 ; 9 : 299-300.
23. FEGUEUX S, DE TRUCHIS P, BALLOUL H et al. : Sulfadiazine desensitization in AIDS patients. AIDS 1991 ; 5 : 1275-6,